CN103768552A - Medicine for treating asthma - Google Patents
Medicine for treating asthma Download PDFInfo
- Publication number
- CN103768552A CN103768552A CN201210416382.7A CN201210416382A CN103768552A CN 103768552 A CN103768552 A CN 103768552A CN 201210416382 A CN201210416382 A CN 201210416382A CN 103768552 A CN103768552 A CN 103768552A
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- gram
- rhizoma
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention belongs to traditional Chinese medicine composition and particularly relates to a medicine for treating asthma. The medicine is characterized by comprising the following raw materials by weight: 15-25 g of apricot kernel, 10-22 g of schisandra chinensis, 5-15 g of indigowoad root, 5-15 g of fresh ginger, 6-10 g of ephedra, 6-12 g of asarum, 6-12 g of aster, 6-12 g of flos farfarae, 6-12 g of pinellia ternate, 4-8 g of rhizoma arisaematis and 2-5 g of radix glycyrrhizae. Since Chinese medicinal herbs are selected as raw materials, the medicine is non-toxic and harmless to human bodies; the effects of the traditional Chinese medicines are used comprehensively, so that the medicine can be used for treating asthma effectively; all traditional Chinese medicines are combined together and supplement each other, so that the effects of clearing heat and detoxifying, and nourishing kidney and moistening lung are achieved. Because lung governs respiration and kidney governs inspiration, body fluid is dispersed, and water liquid is steamed. Therefore, the purpose of treating asthma is achieved.
Description
Technical field
The invention belongs to Chinese medicine composition, relate in particular to a kind of medicine for the treatment of asthma.
Background technology
Heavy breathing in asthma is in larynx, to have expectorant, breathes heavily side of body shoulder rapid breathing, different with heavy breathing, common heavy breathing disease has concurrently more breathes heavily, and the person of breathing heavily has the asthma person that do not hold concurrently, but is mostly because tracheal stenosis, pulmonary's elastic force not with timeliness spasm, or mucosa swelling and paracrisis breathing form; Asthma is divided into the large class of deficiency and excess two by the traditional Chinese medical science, and deficiency syndrome are sent out and mostly are the deficiency of the lung or suffer from a deficiency of the kidney, and the deficiency of the lung is lack of strength in breathing, and speech sound is low, and s cough is light, and expectoration is unable, in the time that climate change or special odor stimulate, brings out, and the vigour of suffering from a deficiency of the kidney is taken the photograph to receive and had no right, and short breath, easily breathes heavily etc. easily; Excess syndrome is divided into cold and heat two classes, and it is clear rare few that cold class shows as expectoration, the expectorant cystose that is white in color, and choking sensation over the chest and dyspnea, the thirsty desire for hot drinks of mouth, white and slippery fur, arteries and veins is how floating tight, or double aversion to cold, heating etc.; Hot class, the yellow stiff of expectorant, is difficult to expectoration, fever of the body and red, thirst and liking drink, red tongue, yellow and greasy fur, slippery and rapid pulse, what have has the symptoms such as heating concurrently.At present, the medicine for the treatment of asthma can be divided into controls medicine and cushion, controls medicine and refers to the medicine that needs use long-term every day.These drug mains will make asthma maintain clinic control by antiinflammatory action, contribute to reduce the medicine of whole body hormone dosage etc. comprising inhaled (abbreviation hormone) hormone for whole body, leukotrienes regulator, long acting β_2 agonistics (long-acting Β 2-receptor stimulating agent, must with suck hormons application), sustained-release theophyline, anti-IgE antibodies and other; Cushion refers to the medicine using as required.Thereby these medicines are by removing rapidly bronchospasm relieving asthma symptoms, comprising quick-acting suction broxaterols, hormone, imbedibility anticholinergic agents, fugitive theophylline and fugitive oral broxaterol etc. for whole body, wherein hormone is the medicine of the most effectively controlling airway inflammation, comprises the dermal ecchymosis, adrenal function inhibition and Decrease of Bone Mineral Density etc. but long-term high dose sucks the systemic adverse reactions that may occur after hormone.
Summary of the invention
Object of the present invention is exactly the deficiency for existing treatment asthma technology, and a kind of medicine for the treatment of asthma is provided, and has no side effect, and can effectively control and treat asthma.
The technical solution adopted for the present invention to solve the technical problems is: a kind of medicine for the treatment of asthma, it is characterized in that, and the crude drug of making effective ingredient by following weight is: Semen Armeniacae Amarum 15-25 gram, Fructus Schisandrae Chinensis 10-22 gram, Radix Isatidis 5-15, Rhizoma Zingiberis Recens 5-15 gram, Herba Ephedrae 6-10 gram, Herba Asari 6-12 gram, Radix Asteris 6-12 gram, Flos Farfarae 6-12 gram, Rhizoma Pinelliae 6-12 gram, Rhizoma Arisaematis 4-8 gram, Radix Glycyrrhizae 2-5 gram.
Further technical scheme of the present invention is: a kind of medicine for the treatment of asthma, it is characterized in that, and the crude drug of making effective ingredient by following weight is: 20 grams, Semen Armeniacae Amarum, 16 grams of Fructus Schisandrae Chinensis, Radix Isatidis 10,10 grams, Rhizoma Zingiberis Recens, 8 grams, Herba Ephedrae, 8 grams of Herba Asaris, 8 grams of Radix Asteriss, 8 grams of Flos Farfaraes, 8 grams of the Rhizoma Pinelliaes, 6 grams of Rhizoma Arisaematiss, 3 grams, Radix Glycyrrhizae.
The present invention is by the treatment of clinical 50 cases, and cure rate reaches 90 %, patient's age between 20-60 year, medication after three days to seven days above-mentioned symptom substantially disappear.This pharmaceutical composition all selects Chinese medicine to be raw material, nontoxic to human body, and utilizes the comprehensive function of various Chinese medicines, effectively treats asthma.Semen Armeniacae Amarum in side, Radix Asteris, Flos Farfarae are medicine for the treatment of cough and asthma, warm in nature, have nourishing the lung to arrest cough, are longer than and reduce phlegm, and are suitable for various coughs; Herba Ephedrae, Rhizoma Zingiberis Recens, Herba Asari add Radix Isatidis, have relieving asthma, effect of warming the lung to relieve cough, heat-clearing and toxic substances removing; Fructus Schisandrae Chinensis, nourishing kidney is promoted the production of body fluid, mind tranquilizing and the heart calming; Radix Glycyrrhizae heat-clearing and toxic substances removing, expelling phlegm for arresting cough; The Rhizoma Pinelliae, Rhizoma Arisaematis drying dampness to eliminate phlegm; By all medicine compatibilities, between medicine, complement each other, played heat-clearing and toxic substances removing, the effect of nourishing kidney lung moistening, the lung governing exhalation, can spreading body fluid, kidney governing inspiration, can evaporate water liquid, thereby reach the object for the treatment of asthma.
The specific embodiment
Embodiment 1: take raw material by following weight: 15 grams, Semen Armeniacae Amarum, 22 grams of Fructus Schisandrae Chinensis, Radix Isatidis 5,15 grams, Rhizoma Zingiberis Recens, 6 grams, Herba Ephedrae, 12 grams of Herba Asaris, 6 grams of Radix Asteriss, 12 grams of Flos Farfaraes, 6 grams of the Rhizoma Pinelliaes, 8 grams of Rhizoma Arisaematiss, 2 grams, Radix Glycyrrhizae.
Embodiment 2: take raw material by following weight: 20 grams, Semen Armeniacae Amarum, 16 grams of Fructus Schisandrae Chinensis, Radix Isatidis 10,10 grams, Rhizoma Zingiberis Recens, 8 grams, Herba Ephedrae, 8 grams of Herba Asaris, 8 grams of Radix Asteriss, 8 grams of Flos Farfaraes, 8 grams of the Rhizoma Pinelliaes, 6 grams of Rhizoma Arisaematiss, 3 grams, Radix Glycyrrhizae.
Embodiment 3: take raw material by following weight: 25 grams, Semen Armeniacae Amarum, 10 grams of Fructus Schisandrae Chinensis, Radix Isatidis 15,5 grams, Rhizoma Zingiberis Recens, 10 grams, Herba Ephedrae, 6 grams of Herba Asaris, 12 grams of Radix Asteriss, 6 grams of Flos Farfaraes, 12 grams of the Rhizoma Pinelliaes, 4 grams of Rhizoma Arisaematiss, 5 grams, Radix Glycyrrhizae.
Claims (2)
1. a medicine for the treatment of asthma, is characterized in that, the crude drug of making effective ingredient by following weight is: Semen Armeniacae Amarum 15-25 gram, Fructus Schisandrae Chinensis 10-22 gram, Radix Isatidis 5-15, Rhizoma Zingiberis Recens 5-15 gram, Herba Ephedrae 6-10 gram, Herba Asari 6-12 gram, Radix Asteris 6-12 gram, Flos Farfarae 6-12 gram, Rhizoma Pinelliae 6-12 gram, Rhizoma Arisaematis 4-8 gram, Radix Glycyrrhizae 2-5 gram.
2. the medicine for the treatment of according to claim 1 asthma, is characterized in that, the crude drug of making effective ingredient by following weight is: 20 grams, Semen Armeniacae Amarum, 16 grams of Fructus Schisandrae Chinensis, Radix Isatidis 10,10 grams, Rhizoma Zingiberis Recens, 8 grams, Herba Ephedrae, 8 grams of Herba Asaris, 8 grams of Radix Asteriss, 8 grams of Flos Farfaraes, 8 grams of the Rhizoma Pinelliaes, 6 grams of Rhizoma Arisaematiss, 3 grams, Radix Glycyrrhizae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210416382.7A CN103768552A (en) | 2012-10-27 | 2012-10-27 | Medicine for treating asthma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210416382.7A CN103768552A (en) | 2012-10-27 | 2012-10-27 | Medicine for treating asthma |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103768552A true CN103768552A (en) | 2014-05-07 |
Family
ID=50561612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210416382.7A Pending CN103768552A (en) | 2012-10-27 | 2012-10-27 | Medicine for treating asthma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103768552A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104887885A (en) * | 2015-06-18 | 2015-09-09 | 杨美娟 | Traditional Chinese medicine for asthma treatment |
CN108452128A (en) * | 2018-05-24 | 2018-08-28 | 江苏苏南药业实业有限公司 | A kind of Chinese medical extract and its preparation method and application for treating bronchial asthma |
CN108653694A (en) * | 2018-06-21 | 2018-10-16 | 王涛 | A kind of spontaneous heating acupoint plaster for treating children's dyspneic cough |
CN109045195A (en) * | 2018-10-18 | 2018-12-21 | 申永吉 | A kind of Chinese medicine composition that treating respiratory disease and its application |
-
2012
- 2012-10-27 CN CN201210416382.7A patent/CN103768552A/en active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104887885A (en) * | 2015-06-18 | 2015-09-09 | 杨美娟 | Traditional Chinese medicine for asthma treatment |
CN108452128A (en) * | 2018-05-24 | 2018-08-28 | 江苏苏南药业实业有限公司 | A kind of Chinese medical extract and its preparation method and application for treating bronchial asthma |
CN108653694A (en) * | 2018-06-21 | 2018-10-16 | 王涛 | A kind of spontaneous heating acupoint plaster for treating children's dyspneic cough |
CN109045195A (en) * | 2018-10-18 | 2018-12-21 | 申永吉 | A kind of Chinese medicine composition that treating respiratory disease and its application |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104352587B (en) | A kind of ointment for treating rhinitis | |
CN103768552A (en) | Medicine for treating asthma | |
CN110354229A (en) | A kind of clearing damp tranquilizing the mind sachet and its preparation method and application | |
CN101850092A (en) | Medicament for treating trauma and preparation method thereof | |
CN100493595C (en) | Infrared cough relieving paste | |
CN103385941B (en) | Chinese herbal medicine analgesic moxibustion | |
CN103720762B (en) | Treat rhinitis fumigant and preparation method thereof | |
CN104225126A (en) | Phlegm dissolving and cough quenching paste | |
CN101129755A (en) | Orally taken traditional Chinese medicine composition for treating asthma | |
CN103623161B (en) | A kind of Traditional Chinese medicinal prescription treating chronic bronchitis | |
CN106540229A (en) | A kind of exterior-applied medical wine for treating cold pain disease and preparation method thereof | |
CN105412826A (en) | Pharmaceutical composition for treating bronchialasthma and application thereof | |
CN104958395A (en) | Traditional Chinese medicine composition for treating cold-with-dampness type cough | |
CN105012594A (en) | Traditional Chinese medicine for treating knee osteoarthritis | |
CN104147334A (en) | Traditional Chinese medicine formula capable of eliminating phlegm | |
CN103536673B (en) | Topical powder with strong enhanced immunity for removing food retention, bringing down fever and relieving cough and asthma, and application thereof | |
CN108785634A (en) | A kind of Chinese medicine composition of prevention of asthma | |
CN103520415A (en) | Medicament for treating traumatic injuries | |
CN103212039A (en) | Traditional Chinese medicine composition for treating infantile cough caused by qi deficiency | |
CN107469061A (en) | A kind of inflammation-diminishing and cough-controlling traditional Chinese powder medicine and preparation method thereof | |
CN102293915A (en) | Traditional Chinese medicinal composition for treating emphysema of horses | |
CN106110217A (en) | A kind of medicated wine for treating cervical spondylosis | |
CN105878878A (en) | Cough black plaster | |
CN106177572A (en) | A kind of Chinese medicine decoction treating aplastic anemia | |
CN105168838A (en) | Traditional Chinese medicine composition for treating sphagitis and preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140507 |